Summarecon Agung Tbk PT
IDX:SMRA
Summarecon Agung Tbk PT
IDX:SMRA
Price:
705
IDR
3.68%
Market Cap:
11.6T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SMRA Alert
Summarecon Agung Tbk PT
705
+25 (+3.68%)
| 52 Week Range |
480
705
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Summarecon Agung Tbk PT
Balance Sheet
Balance Sheet Decomposition
Summarecon Agung Tbk PT
Summarecon Agung Tbk PT
| Current Assets | 15.6T |
| Cash & Short-Term Investments | 3.4T |
| Receivables | 280.5B |
| Other Current Assets | 11.9T |
| Non-Current Assets | 16.3T |
| Long-Term Investments | 14T |
| PP&E | 451.1B |
| Other Non-Current Assets | 1.9T |
| Current Liabilities | 12.6T |
| Accounts Payable | 85.9B |
| Accrued Liabilities | 907.9B |
| Short-Term Debt | 3.4T |
| Other Current Liabilities | 8.2T |
| Non-Current Liabilities | 8.9T |
| Long-Term Debt | 3.3T |
| Other Non-Current Liabilities | 5.7T |
Balance Sheet
Summarecon Agung Tbk PT
Summarecon Agung Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 695 077
|
1 503 546
|
2 076 201
|
1 473 752
|
1 523 848
|
1 664 424
|
1 656 482
|
2 773 938
|
3 142 558
|
3 292 877
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 180 189
|
|
| Cash Equivalents |
1 695 077
|
1 503 546
|
2 076 201
|
1 473 752
|
1 523 848
|
1 664 424
|
1 656 482
|
2 773 938
|
3 142 558
|
2 112 688
|
|
| Short-Term Investments |
375
|
104
|
107
|
146
|
60
|
5 163
|
171
|
3 641
|
3 968
|
13 676
|
|
| Total Receivables |
85 514
|
152 036
|
548 310
|
660 831
|
411 705
|
243 104
|
275 593
|
279 963
|
307 949
|
247 470
|
|
| Accounts Receivables |
76 412
|
145 921
|
539 087
|
645 416
|
393 868
|
220 913
|
256 538
|
249 079
|
293 871
|
235 912
|
|
| Other Receivables |
9 102
|
6 115
|
9 223
|
15 416
|
17 837
|
22 191
|
19 055
|
30 884
|
14 079
|
11 558
|
|
| Inventory |
3 103 252
|
4 924 807
|
5 531 047
|
6 498 457
|
7 890 253
|
8 514 332
|
9 186 988
|
9 253 913
|
9 959 606
|
10 906 023
|
|
| Other Current Assets |
581 490
|
709 189
|
543 152
|
554 674
|
672 229
|
723 721
|
769 683
|
719 081
|
876 540
|
1 102 183
|
|
| Total Current Assets |
5 465 707
|
7 289 682
|
8 698 817
|
9 187 860
|
10 498 095
|
11 150 745
|
11 888 918
|
13 030 536
|
14 290 621
|
15 562 229
|
|
| PP&E Net |
366 762
|
420 472
|
451 343
|
421 579
|
376 729
|
338 339
|
331 696
|
317 847
|
370 445
|
442 053
|
|
| PP&E Gross |
366 762
|
420 472
|
451 343
|
421 579
|
376 729
|
338 339
|
331 696
|
317 847
|
370 445
|
442 053
|
|
| Accumulated Depreciation |
325 281
|
409 341
|
504 485
|
592 647
|
626 452
|
703 042
|
749 396
|
795 351
|
849 111
|
904 479
|
|
| Note Receivable |
524
|
56 096
|
39 863
|
40 101
|
51 114
|
44 108
|
55 065
|
35 871
|
67 056
|
22 365
|
|
| Long-Term Investments |
8 460 407
|
10 148 201
|
10 870 984
|
11 185 275
|
11 538 747
|
11 977 030
|
11 803 676
|
11 606 143
|
12 559 503
|
13 711 123
|
|
| Other Long-Term Assets |
1 086 079
|
843 811
|
749 313
|
828 137
|
834 557
|
931 435
|
843 180
|
1 059 320
|
1 145 950
|
1 430 606
|
|
| Total Assets |
15 379 479
N/A
|
18 758 262
+22%
|
20 810 320
+11%
|
21 662 951
+4%
|
23 299 242
+8%
|
24 441 657
+5%
|
24 922 534
+2%
|
26 049 717
+5%
|
28 433 575
+9%
|
31 168 375
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
64 656
|
63 007
|
57 614
|
80 937
|
76 741
|
86 134
|
80 677
|
70 858
|
87 415
|
91 416
|
|
| Accrued Liabilities |
405 627
|
1 697 307
|
1 515 289
|
1 195 747
|
1 026 276
|
1 174 972
|
740 073
|
816 056
|
1 104 004
|
1 082 318
|
|
| Short-Term Debt |
289 308
|
808 553
|
1 040 799
|
905 840
|
1 782 155
|
2 139 382
|
2 670 935
|
1 590 250
|
2 018 403
|
2 766 358
|
|
| Current Portion of Long-Term Debt |
216 736
|
174 880
|
361 511
|
1 488 750
|
1 931 514
|
2 512 622
|
1 299 154
|
1 328 731
|
606 555
|
992 427
|
|
| Other Current Liabilities |
3 016 271
|
1 665 939
|
1 242 158
|
2 604 553
|
2 412 532
|
3 104 222
|
3 568 316
|
3 162 871
|
5 684 898
|
6 853 195
|
|
| Total Current Liabilities |
3 992 598
|
4 409 686
|
4 217 372
|
6 275 828
|
7 229 217
|
9 017 332
|
8 359 155
|
6 968 766
|
9 501 274
|
11 785 714
|
|
| Long-Term Debt |
3 876 437
|
5 214 386
|
6 024 332
|
5 589 119
|
4 892 933
|
4 317 002
|
5 487 991
|
4 126 042
|
3 289 565
|
3 444 561
|
|
| Deferred Income Tax |
1 068
|
1 150
|
2 291
|
3 713
|
3 156
|
32 211
|
25 158
|
19 387
|
17 986
|
14 571
|
|
| Minority Interest |
495 769
|
1 516 936
|
1 922 597
|
1 843 841
|
2 157 113
|
2 083 714
|
2 239 843
|
2 569 055
|
2 552 635
|
2 476 252
|
|
| Other Liabilities |
1 516 740
|
1 603 289
|
2 400 770
|
1 440 549
|
2 113 232
|
1 623 752
|
1 964 541
|
3 705 298
|
3 874 709
|
3 620 467
|
|
| Total Liabilities |
9 882 612
N/A
|
12 745 448
+29%
|
14 567 361
+14%
|
15 153 049
+4%
|
16 395 651
+8%
|
17 074 011
+4%
|
18 076 688
+6%
|
17 388 549
-4%
|
19 236 169
+11%
|
21 341 565
+11%
|
|
| Equity | |||||||||||
| Common Stock |
1 442 678
|
1 442 678
|
1 442 678
|
1 442 678
|
1 442 678
|
1 442 678
|
1 442 678
|
1 650 857
|
1 650 857
|
1 650 857
|
|
| Retained Earnings |
4 029 681
|
4 545 366
|
4 775 726
|
5 042 670
|
5 436 359
|
5 900 414
|
5 381 836
|
5 704 773
|
6 241 011
|
6 870 415
|
|
| Additional Paid In Capital |
22 996
|
22 996
|
22 996
|
22 996
|
22 996
|
22 996
|
22 996
|
1 307 203
|
1 307 203
|
1 307 203
|
|
| Other Equity |
1 511
|
1 773
|
1 557
|
1 557
|
1 557
|
1 557
|
1 665
|
1 665
|
1 665
|
1 665
|
|
| Total Equity |
5 496 867
N/A
|
6 012 814
+9%
|
6 242 958
+4%
|
6 509 901
+4%
|
6 903 591
+6%
|
7 367 646
+7%
|
6 845 846
-7%
|
8 661 168
+27%
|
9 197 406
+6%
|
9 826 810
+7%
|
|
| Total Liabilities & Equity |
15 379 479
N/A
|
18 758 262
+22%
|
20 810 320
+11%
|
21 662 951
+4%
|
23 299 242
+8%
|
24 441 657
+5%
|
24 922 534
+2%
|
26 049 717
+5%
|
28 433 575
+9%
|
31 168 375
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
14 427
|
14 427
|
14 889
|
14 889
|
14 889
|
14 889
|
14 889
|
16 509
|
16 509
|
16 509
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
